Ever since going out on its own, Covidien (NYSE: COV )
has had a knack for doing deals that left many analysts and investors
scratching their heads initially, only to generate better-than-expected
revenue and margin synergies from the deals in the years afterward.
Coviden is going back to the well again, buying Given Imaging (NASDAQ: GIVN ) and further building its efforts in the $3 billion GI market.
Please follow this link to the full article:
A Sneaky-Smart Med-Tech Buyer Does It Again
No comments:
Post a Comment